Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)

Mise à jour : Il y a 4 ans
Référence : NCT00345735

Femme et Homme

  • | Pays :
  • Denmark
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Primary Objective: To demonstrate the efficacy of intranasal fentanyl in the treatment of breakthrough pain (BTP) in cancer patients. Secondary Objective: To explore the relationship between the response to the fentanyl dose and the stable background pain opioid dose.


Critère d'inclusion

  • Cancer ,pain

Liens